Effects of HER2 and HER3 on EGFR trafficking and localization - a modelling study

被引：0
|
作者：
Resat, H
Shankaran, H
Wiley, H
机构：
[1] Pacific NW Natl Lab, Computat BioSci Grp, Richland, WA USA
[2] Pacific NW Natl Lab, Div Biol Sci, Richland, WA USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
68
引用
收藏
页码：13A / 13A
页数：1
相关论文
共 50 条
  • [21] Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
    Andrea Sassen
    Justine Rochon
    Peter Wild
    Arndt Hartmann
    Ferdinand Hofstaedter
    Stephan Schwarz
    Gero Brockhoff
    [J]. Breast Cancer Research, 10
  • [22] Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
    Sassen, Andrea
    Rochon, Justine
    Wild, Peter
    Hartmann, Arndt
    Hofstaedter, Ferdinand
    Schwarz, Stephan
    Brockhoff, Gero
    [J]. BREAST CANCER RESEARCH, 2008, 10 (01):
  • [23] Quantitative analysis of HER2 expression level effects on EGFR trafficking
    Hendriks, BS
    Opresko, L
    Wiley, HS
    Lauffenburger, DA
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 502A - 502A
  • [24] HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib
    Wehrenberg-Klee, Eric
    Sinevici, Nicoleta
    Nesti, Sarah
    Kalomeris, Taylor
    Austin, Emily
    Larimer, Benjamin
    Mahmood, Umar
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (06) : 930 - 940
  • [25] Essential role of Her3 in two signaling transduction patterns: Her2/Her3 and MET/Her3 in proliferation of human gastric cancer
    Yun, Chen
    Gang, Li
    Gu Rongmin
    Xu, Wen
    Ming Xuezhi
    Chen Huanqiu
    [J]. MOLECULAR CARCINOGENESIS, 2015, 54 (12) : 1700 - 1709
  • [26] Occurrence of de Novo Dual HER2/HER3 or HER2/EGFR TMD Mutations: Extending the Spectrum of Targetable Mono-HER2 TMD in NSCLC?
    Ou, S.
    Schrock, A.
    Bocharov, E.
    Lee, J.
    Madison, R.
    Gay, L.
    Miller, V.
    Alexander, B.
    Husain, H.
    Riess, J.
    Ali, S.
    Velcheti, V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S394 - S394
  • [27] HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib
    Eric Wehrenberg-Klee
    Nicoleta Sinevici
    Sarah Nesti
    Taylor Kalomeris
    Emily Austin
    Benjamin Larimer
    Umar Mahmood
    [J]. Molecular Imaging and Biology, 2021, 23 : 930 - 940
  • [28] The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination
    Balz, Lydia M.
    Bartkowiak, Kai
    Andreas, Antje
    Pantel, Klaus
    Niggemann, Bernd
    Zaenker, Kurt S.
    Brandt, Burkhard H.
    Dittmar, Thomas
    [J]. JOURNAL OF PATHOLOGY, 2012, 227 (02): : 234 - 244
  • [29] Overexpression of HER2/HER3 and clinical feature of ovarian cancer
    Chung, Ye Won
    Kim, Seongmin
    Hong, Jin Hwa
    Lee, Jae Kwan
    Lee, Nak Woo
    Lee, Young Seok
    Song, Jae Yun
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (05)
  • [30] Mutant HER2 needs mutant HER3 to be an effective oncogene
    Trenker, Raphael
    Diwanji, Devan
    Jura, Natalia
    [J]. CELL REPORTS MEDICINE, 2021, 2 (08)
12345